IRIS Accounts Production v24.3.2.46 07733569 director 1.1.24 31.12.24 31.12.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh077335692023-12-31077335692024-12-31077335692024-01-012024-12-31077335692022-08-31077335692022-09-012023-12-31077335692023-12-3107733569ns15:EnglandWales2024-01-012024-12-3107733569ns14:PoundSterling2024-01-012024-12-3107733569ns10:Director12024-01-012024-12-3107733569ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3107733569ns10:SmallEntities2024-01-012024-12-3107733569ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3107733569ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3107733569ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3107733569ns10:FullAccounts2024-01-012024-12-3107733569ns5:CurrentFinancialInstruments2024-12-3107733569ns5:CurrentFinancialInstruments2023-12-3107733569ns5:ShareCapital2024-12-3107733569ns5:ShareCapital2023-12-3107733569ns5:RetainedEarningsAccumulatedLosses2024-12-3107733569ns5:RetainedEarningsAccumulatedLosses2023-12-3107733569ns10:RegisteredOffice2024-01-012024-12-3107733569ns5:FurnitureFittings2024-01-012024-12-3107733569ns5:ComputerEquipment2024-01-012024-12-3107733569ns5:FurnitureFittings2023-12-3107733569ns5:ComputerEquipment2023-12-3107733569ns5:FurnitureFittings2024-12-3107733569ns5:ComputerEquipment2024-12-3107733569ns5:FurnitureFittings2023-12-3107733569ns5:ComputerEquipment2023-12-3107733569ns5:AdditionsToInvestments2024-12-3107733569ns5:CostValuation2024-12-3107733569ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3107733569ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-31077335691ns10:Director12023-12-31077335691ns10:Director12022-08-31077335691ns10:Director12024-01-012024-12-31077335691ns10:Director12022-09-012023-12-31077335691ns10:Director12024-12-31077335691ns10:Director12023-12-31
REGISTERED NUMBER: 07733569 (England and Wales)











UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

BB ORAL HEALTH LIMITED

BB ORAL HEALTH LIMITED (REGISTERED NUMBER: 07733569)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024










Page

Balance Sheet 1

Notes to the Financial Statements 2


BB ORAL HEALTH LIMITED (REGISTERED NUMBER: 07733569)

BALANCE SHEET
31 DECEMBER 2024

2024 2023
Notes £    £   
FIXED ASSETS
Tangible assets 4 204 305
Investments 5 3,846 -
4,050 305

CURRENT ASSETS
Debtors 6 43,320 65,605
Cash at bank 90,022 130,538
133,342 196,143
CREDITORS
Amounts falling due within one year 7 (24,311 ) (32,941 )
NET CURRENT ASSETS 109,031 163,202
TOTAL ASSETS LESS CURRENT LIABILITIES 113,081 163,507

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 113,079 163,505
SHAREHOLDERS' FUNDS 113,081 163,507

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 25 March 2025 and were signed by:





B Bonito - Director


BB ORAL HEALTH LIMITED (REGISTERED NUMBER: 07733569)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024


1. STATUTORY INFORMATION

BB Oral Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 07733569

Registered office: 15 West Street
Brighton
East Sussex
BN1 2RL

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents the consideration received or receivable for services provided by the company and is measured at fair value, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% on reducing balance

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Investments in subsidiaries
Investments in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals are recognised immediately to profit and loss.

Financial instruments
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

Taxation
Taxation for the year comprises current tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES

The average number of employees during the year was 1 (2023 - 1 ) .

BB ORAL HEALTH LIMITED (REGISTERED NUMBER: 07733569)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 January 2024 1,164 2,352 3,516
Disposals - (1,001 ) (1,001 )
At 31 December 2024 1,164 1,351 2,515
DEPRECIATION
At 1 January 2024 980 2,231 3,211
Charge for year 46 21 67
Eliminated on disposal - (967 ) (967 )
At 31 December 2024 1,026 1,285 2,311
NET BOOK VALUE
At 31 December 2024 138 66 204
At 31 December 2023 184 121 305

5. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
Additions 3,846
At 31 December 2024 3,846
NET BOOK VALUE
At 31 December 2024 3,846

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Amounts owed by group undertakings 40,354 -
Directors' current accounts - 51,370
Prepayments and accrued income 2,966 14,235
43,320 65,605

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Tax 19,659 28,730
Social security and other taxes 2,204 87
Directors' current accounts 468 -
Accruals and deferred income 1,980 4,124
24,311 32,941

BB ORAL HEALTH LIMITED (REGISTERED NUMBER: 07733569)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the year ended 31 December 2024 and the period ended 31 December 2023:

2024 2023
£    £   
B Bonito
Balance outstanding at start of year 51,370 (834 )
Amounts advanced 76,310 94,527
Amounts repaid (128,148 ) (42,323 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (468 ) 51,370